24/02/2023
Hybrid Congress - PRBB Auditorium - www.ragm.online (08:30h - 14:00h)
On 24 February 2023 will take place a new edition of "Recent Advances in Genitourinary Malignancies (RAGM-2023)" organized by IMIM, Genesis Care and Clínica Corachan and directed by Dr. Joaquim Bellmunt , Dr. Escarlata López and Dr. Juan Pablo Fusco from Genesis Care.
For more information please click https://www.ragm.online/
Registration is already open and it's free.
How to register?
Access to: https://eira.meetingpharma.com/courses/ragm23
Once you are registered introduce the coupon-code: RAGM2023
08:00 - 08:30 Registration
08:30 - 08:35 Welcome and Opening Dr. Joan Albanell & Dr. Escarlata López
08:35 - 08:40 Welcome from Dr. Wally Curran, GenesisCare Global CMO
08:40 - 10:05 Round Table 1: Prostatic Cancer
Moderator: Dr. Escarlata López
08:40 - 08:45 Presentation
08:45 - 09:00 Precision medicine in prostatic cancer
Dr. Neal Shore
09:00 - 09:15 Theragnostics in prostatic cancer
Dr. Nat Lenzo
09:15 - 09:30 New ARTA agents in advanced prostate cancer Dr. José Luis Pérez Gracia
09:30 - 09:45 New era of radiotherapy treatments in radioncology. Dr Vladimir Suárez
09:45 - 10:05 Discussion
10:05 - 10:35 Keynote lecture
Presentation: Dr. Joaquin Bellmunt and Dr. Joaquin Arribas
Responding to the climate emergency: actions we can take. William R. Moomaw
10:35 - 10:45 Coffee break
10:45 - 11:55 Round Table 2: Bladder Cancer
Moderator: Dr. Joaquim Bellmunt
10:45 - 10:50 Presentation
10:50 - 11:05 Ongoing trials in Neoad/Adjuvant therapy in MIBC. Dr. Petros Grivas.
11:05 - 11:20 Maintenance immunotherapy in bladder cancer what the future holds. Dr. Begoña Pérez Valderrama
11:20 - 11:35 Future treatment algorithm on sequencing
therapies. Role of Antibody drug conjugates. Dr. Thomas Powles
11:35 - 11:55 Discussion
11:55 - 13:50 Round Table 3: Kidney Cancer
Moderator: Dr. Juan Pablo Fusco
11:55 - 12:10 Clinical Case - Questions
12:10 - 12:25 Presentation
12:25 - 12:40 Adjuvant immunotherapy in renal cell carcinoma
Dr.Pablo Maroto
12:40 - 12:55 Relevant aspects to select the first line of treatment in metastatic renal cell carcinoma patients
Dr. Cristina Suárez
12:55 - 13:10 Second line treatment in metastatic renal cell
carcinoma patients. Dr. McDermott
13:10 - 13:25 Rol of SBRT in olimotastatic renal cell carcinoma
Dr. Miguel Montijano
13:25 - 13:50 Discussion
13:50 - 14:00 Closing remarks
Dr. Joaquim Bellmunt and Dr. Escarlata López
______________________________________________________
Contact
Meeting Pharma, A/A Asun Torres
atorres@meetingpharma.com
© Institut Hospital del Mar
d'Investigacions MèdiquesAvís Legal i Política de Privacitat | Política de cookies | Mapa web | Accessibilitat | Adreça / Accessos | Contacte